Support for the Introduction of Highly Effective Artemisinin - Based Combination Therapy Malaria Treatment
Malaria is the leading cause of illness and death in Uganda. The major factor contributing to this is low access to and use of insecticide-treated bed nets. The program supported by this grant focuses on increasing the availability of highly effective anti-malaria treatment using artemisinin-based combination therapy in Uganda to improve case management and prevention of malaria in health facilities. The program is also focusing on ensuring demand for and correct and efficient use of highly effective malaria treatment and implementing artemisinin-based combination therapy in communities using the home-based management of fever strategy. The program targets children under age five, pregnant women and the general population.
- ID Projet
47045-UGD-405-G05-M- Statut de l'activité
- 3 - Completion
- Type d'aide
- C01 - Interventions de type projet
- % to Ouganda
- 100.00
Organisations
- Funding
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
- Implementing
- Ministry of Finance, Planning and Economic Development of the Republic of Uganda
Versements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
| 2015 |
Q1 |
-133,261.00 |
-133,261.00 |
| 2011 |
Q4 |
6,553,335.00 |
6,553,335.00 |
| 2011 |
Q2 |
5,554,024.00 |
5,554,024.00 |
| 2010 |
Q3 |
24,781,064.00 |
24,781,064.00 |
| 2009 |
Q4 |
9,725,326.00 |
9,725,326.00 |
| 2009 |
Q3 |
24,781,064.00 |
24,781,064.00 |
| 2009 |
Q1 |
22,371.00 |
22,371.00 |
| 2008 |
Q4 |
60,908.00 |
60,908.00 |
| 2008 |
Q3 |
548,146.00 |
548,146.00 |
| 2008 |
Q2 |
440,902.00 |
440,902.00 |
| 2008 |
Q1 |
11,057.00 |
11,057.00 |
| 2007 |
Q4 |
33,190.00 |
33,190.00 |
| 2007 |
Q3 |
13,786,077.00 |
13,786,077.00 |
| 2007 |
Q2 |
1,387,032.00 |
1,387,032.00 |
| 2007 |
Q1 |
303,627.00 |
303,627.00 |
| 2006 |
Q4 |
5,894,549.00 |
5,894,549.00 |
| 2006 |
Q3 |
16,468,532.00 |
16,468,532.00 |
| 2006 |
Q2 |
16,499,787.00 |
16,499,787.00 |
| 2006 |
Q1 |
79,721.00 |
79,721.00 |
| 2005 |
Q4 |
129,717.00 |
129,717.00 |
| 2005 |
Q3 |
968,339.00 |
968,339.00 |
| 2005 |
Q2 |
59,549,408.00 |
59,549,408.00 |
Engagements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
| 2015 |
Q1 |
-133,261.00 |
-133,261.00 |
| 2013 |
Q4 |
-3,140,249.00 |
-3,140,249.00 |
| 2013 |
Q3 |
40,028,672.00 |
40,028,672.00 |
| 2005 |
Q2 |
59,071,374.00 |
59,071,374.00 |
Projections de CDMT par exercice fiscal
| Exercice fiscal |
Montant (USD) |
Ouganda Montant (USD) |
| 2012 |
2,213,191.00 |
2,213,191.00 |
| 2011 |
19,230,440.00 |
19,230,440.00 |
| 2010 |
7,849,206.50 |
7,849,206.50 |
| 2009 |
20,820,793.00 |
20,820,793.00 |
| 2008 |
20,576,515.00 |
20,576,515.00 |
| 2007 |
36,091,036.50 |
36,091,036.50 |
| 2006 |
21,732,824.00 |
21,732,824.00 |
| 2005 |
36,549,513.00 |
36,549,513.00 |
| Code CRS |
% |
|
Lutte contre le paludisme
(12262)
|
100.0
|